Building a functional understanding of the microbiome to transform drug-discovery and improve health outcomes.
About adminThis author has not yet filled in any details.
So far admin has created 40 blog entries.
The annual event brings together industry and academia to discuss the challenges and opportunities in formulations and product development for skin, hair and oral care applications. The event covers a broad range of topics, enabling cross-sector fertilization.
The 2nd annual conference of Skin health and Dermatology as part of the Microbiome Movement was held in San Diego, California in September 2019. Labskin were proud to be both a sponsor and a speaker at the event.
But most of these models are sterile. In recent years, skin microbiota has emerged as a key player in skin health, preventing pathogens proliferation, educating the immune system and maintaining barrier integrity. The first skin models colonized with bacteria have focused on unique bacterial species. But the study of skin diseases (such as atopic dermatitis) revealed that microbiota’s diversity is key to skin health. We thus developed a model that reproduces the complexity of the skin’s ecosystem with an uncultured skin microbiota and compared it to the use of a unique commensal bacteria.
Labskin will be presenting at the second Hemp & CBD Expo at the NEC in Birmingham, UK on September 14th-15th. With specific and relevant experience in the CBD area, Labskin is proud to be a sponsor and speaker at the expo.
Launching a new product containing CBD Oil? In this post we outline the uses of CBD Oil, its current and future regulation and best practice for companies seeking to launch new products containing Cannabidiol (CBD).
Integumen today announces the expansion of its chronic wound care division, LifeScienceHub Ltd (Wound pHase), as it extends its license technology agreement (RNS 16 July 2018) with Cellulac plc (9.35% owned by Integumen).
Labskin will presenting at the Microbiome Movement’s 2nd annual conference on Skin Health and Dermatology.
Lab-to-Market time of skincare products, at a fraction of the cost.
On April 5th, 2017 the EU formally approved the new Medical Devices Regulation, replacing the two existing directives – the Medical Devices Directive, and the Active Implantable Medical Devices Directive.